Total Payments
$745.21
2021 Payments
$22.54
Companies
15
Transactions
40
Medicare Patients
1,485
Medicare Billing
$199,706
Payment Breakdown by Category
Food & Beverage$745.21 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $745.21 | 40 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $118.82 | 9 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $112.83 | 5 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $72.92 | 3 | $0 (2018) |
| PORTOLA PHARMACEUTICALS, INC. | $67.26 | 3 | $0 (2018) |
| Melinta Therapeutics, Inc. | $61.61 | 2 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $61.57 | 3 | $0 (2017) |
| Relypsa, Inc. | $53.73 | 3 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $47.72 | 3 | $0 (2017) |
| Allergan Inc. | $40.16 | 2 | $0 (2018) |
| The Medicines Company | $25.66 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $22.54 | 1 | Novo Nordisk Inc ($22.54) |
| 2019 | $44.75 | 2 | Janssen Pharmaceuticals, Inc ($44.75) |
| 2018 | $355.99 | 17 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($72.92) |
| 2017 | $321.93 | 20 | Otsuka America Pharmaceutical, Inc. ($103.78) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/28/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Diabetes | ||||||
| 09/30/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/07/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/25/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXANIBSD, RELISTOR ORAL | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/23/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Hyperkalemia | ||||||
| 08/06/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/31/2018 | Melinta Therapeutics, Inc. | Baxdela (Drug), Vabomere, Orbactiv | Food and Beverage | In-kind items and services | $34.51 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/27/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Hyperkalemia | ||||||
| 07/11/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/13/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/18/2018 | PORTOLA PHARMACEUTICALS, INC. | BEVYXXA (Drug) | Food and Beverage | Cash or cash equivalent | $18.19 | General |
| Category: CARDIOLOGY/HEMATOLOGY | ||||||
| 04/17/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/10/2018 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/16/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Hyperkalemia | ||||||
| 03/14/2018 | PORTOLA PHARMACEUTICALS, INC. | BEVYXXA (Drug) | Food and Beverage | Cash or cash equivalent | $24.05 | General |
| Category: CARDIOLOGY/HEMATOLOGY | ||||||
| 02/15/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: NEPHROLOGY | ||||||
| 02/06/2018 | PORTOLA PHARMACEUTICALS, INC. | BEVYXXA (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: CARDIOLOGY/HEMATOLOGY | ||||||
| 01/30/2018 | Melinta Therapeutics, Inc. | Vabomere (Drug), Orbactiv, MINOCIN | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 01/25/2018 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/04/2018 | The Medicines Company | ORBACTIV (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/05/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/28/2017 | Valeant Pharmaceuticals North America LLC | XIFIXAN (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/16/2017 | The Medicines Company | ORBACTIV (Drug) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/08/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: RESPIRATORY | ||||||
| 11/02/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 218 | 390 | $131,381 | $29,664 |
| 2022 | 6 | 608 | 1,138 | $384,915 | $83,422 |
| 2021 | 7 | 579 | 1,074 | $321,959 | $81,772 |
| 2020 | 4 | 80 | 80 | $10,101 | $4,847 |
Total Patients
1,485
Total Services
2,682
Medicare Billing
$199,706
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 86 | 212 | $53,330 | $12,379 | 23.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 82 | $30,952 | $7,177 | 23.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 46 | 47 | $29,116 | $6,033 | 20.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 48 | 49 | $17,983 | $4,075 | 22.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 207 | 503 | $182,123 | $39,543 | 21.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 152 | 383 | $96,672 | $21,112 | 21.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 127 | 129 | $48,140 | $10,323 | 21.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 51 | 52 | $36,557 | $7,809 | 21.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 34 | 34 | $12,036 | $2,611 | 21.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 37 | 37 | $9,387 | $2,025 | 21.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 162 | 445 | $148,650 | $37,098 | 25.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 166 | 374 | $78,258 | $21,327 | 27.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 127 | 130 | $43,500 | $10,758 | 24.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 51 | 51 | $32,621 | $7,936 | 24.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 39 | 40 | $9,040 | $2,278 | 25.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 22 | 22 | $7,106 | $1,712 | 24.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 12 | 12 | $2,784 | $663.00 | 23.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 21 | 21 | $2,478 | $1,749 | 70.6% |
| 87635 | Sars-cov-2 covid-19 amp prb | Office | 2020 | 24 | 24 | $3,600 | $1,231 | 34.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 16 | $2,256 | $943.78 | 41.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 19 | 19 | $1,767 | $923.33 | 52.3% |
About Dr. Susan Carter, M.D
Dr. Susan Carter, M.D is a Family Medicine healthcare provider based in Port Angeles, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2013. The National Provider Identifier (NPI) number assigned to this provider is 1326381856.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Carter, M.D has received a total of $745.21 in payments from pharmaceutical and medical device companies, with $22.54 received in 2021. These payments were reported across 40 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($745.21).
As a Medicare-enrolled provider, Carter has provided services to 1,485 Medicare beneficiaries, totaling 2,682 services with total Medicare billing of $199,706. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Port Angeles, WA
- Active Since 04/03/2013
- Last Updated 08/08/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1326381856
Products in Payments
- SAMSCA (Drug) $118.82
- XARELTO (Drug) $112.83
- XIFAXAN (Drug) $112.19
- BEVYXXA (Drug) $67.26
- Veltassa (Drug) $53.73
- ELIQUIS (Drug) $47.72
- DALVANCE (Drug) $40.16
- Baxdela (Drug) $34.51
- Vabomere (Drug) $27.10
- ORBACTIV (Drug) $25.66
- Ozempic (Drug) $22.54
- XIFIXAN (Drug) $22.30
- DIFICID (Drug) $17.93
- LifeVest (Device) $15.06
- BROVANA (Drug) $15.00
- GATTEX (Drug) $12.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Port Angeles
Calvin Kuo, M.d, M.D
Family Medicine — Payments: $2,217
Family Medicine $2,217
Dr. Sophia Tong, Md, MD
Family Medicine — Payments: $548.50
Family Medicine $548.50
John Miller, M.d, M.D
Family Medicine — Payments: $471.50
Family Medicine $471.50
Mr. Phong Dam, Np, NP
Family Medicine — Payments: $243.89
Family Medicine $243.89
Ronald Bergman, M.d, M.D
Family Medicine — Payments: $233.30
Family Medicine $233.30
Samuel Epstein, Md, MD
Family Medicine — Payments: $96.11
Family Medicine $96.11